Jul 24, 2023 | Blog, Shareholder Investigations
Investors of Sculptor Capital Management Stock Encouraged to Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether the sale of Sculptor Capital Management, Inc. (“Sculptor” or “Sculptor Capital”) (NYSE: SCU) to Rithm Capital Corp. for $11.15 per class A share in cash is fair to Sculptor Capital shareholders.
INVESTORS OF SCULPTOR CAPITAL STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C.
The investigation concerns potential breaches of fiduciary duty on the part of Sculptor Capital’s officers and directors in connection with Sculptor’s agreement to be acquired by Rithm Capital and whether Rithm Capital is not paying enough for Sculptor Capital.
SHAREHOLDERS OF SCULPTOR CAPITAL STOCK ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Jun 29, 2023 | Blog, Shareholder Investigations
Investors of BioXcel Stock With Financial Losses of $100,000 or More Encouraged to Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI).
INVESTORS OF BIOXCEL STOCK WHO HAVE SUFFERED SIGNIFICANT FINANCIAL LOSSES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C.
On June 29, 2023, Reuters reported that “BioXcel Therapeutics said on Thursday its experimental drug to treat agitation related to Alzheimer’s disease met the main goal in a late-stage study, but the results were marred by concerns over data integrity at one of the trial sites.”
Reuters also reported that “BioXcel said the principal investigator at the site was found to have fabricated email correspondence related to the timing of reporting serious side-effects to the company’s vendor responsible for monitoring safety of the drug so as to make it appear as though they had been reported in a timely manner as required by the trial protocol.”
On this news, shares of BioXcel stock were down more than 63% during intraday trading on June 29, 2023.
BIOXCEL SHAREHOLDERS WHO HAVE SUFFERED LOSSES OF $100,00 OR MORE ARE ALSO ENCOURAGED TO CONTACT EITHER JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], OR MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Jun 7, 2023 | Blog, Shareholder Investigations
Investors of Goldman Sachs Stock Encouraged to Contact Kehoe Law Firm, P.C. – Breach of Fiduciary Duties Investigation
Kehoe Law Firm, P.C. is investigating whether certain directors and officers of The Goldman Sachs Group, Inc. (“Goldman Sachs”) (NYSE: GS) breached their fiduciary duties to Goldman Sachs and its shareholders.
CURRENT INVESTORS OF GOLDMAN SACHS STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C.
On May 8, 2023, Goldman Sachs announced that it had agreed to pay $215 million to settle a class action lawsuit alleging widespread bias against women in pay and promotions.
SHAREHOLDERS OF GOLDMAN SACHS STOCK ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Jun 1, 2023 | Blog, Shareholder Investigations
Investors of DZS Stock Encouraged to Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of DZS Inc. (“DZS”) (NASDAQ: DZSI).
On June 1, 2023, DZS reported that “. . . it will restate its previously issued financial statements for the first quarter of 2023, which ended March 31, 2023. The restatement relates to timing of revenue recognition with respect to two customer projects. The value of the revenue to be restated is approximately $15 million, of which the company anticipates the majority will be recognized during the second and third quarters of 2023.”
Shares of DZS were down significantly during intraday trading on June 1, 2023.
May 18, 2023 | Blog, Shareholder Investigations
Investors of Bowlero Encouraged to Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Bowlero Corp. (“Bowlero” or the “Company”) (NYSE: BOWL).
INVESTORS OF BOWLERO STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C.
Bowlero recently reported that it “. . . did not design and maintain effective controls over certain financial reporting processes, including acquisition accounting, accounting for fixed assets, and certain financial reporting disclosures.”
The Company also stated that it “. . . did not design and maintain effective controls over system access controls to establish segregation of duties for those with roles and responsibilities for the general ledger.”
Shares of Bowlero stock were down more than 16% during intraday trading on May 18, 2023.
SHAREHOLDERS OF BOWLERO STOCK ARE ALSO ENCOURAGED TO CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
May 18, 2023 | Blog, Shareholder Investigations
Investors of eMagin Encouraged to Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether the sale of eMagin Corporation (“eMagin”) (NYSE: EMAN) to Samsung Display Co., Ltd. for $2.08 per share in cash is fair to eMagin shareholders.
INVESTORS OF eMAGIN STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C.
SHAREHOLDERS OF eMAGIN STOCK ARE ALSO ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
